HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


WellPoint Cancer Drug Pathways Program Aims To Save 4% In Annual Costs

This article was originally published in The Pink Sheet Daily

Executive Summary

When it is fully operational in all 14 WellPoint states, more than 21 million members will be eligible for the initiative to standardize cancer prescribing and lower drug costs.


Related Content

Multiple Myeloma Would Make Good Guinea Pig For Oncology Cost Control
Cancer Pathways Will Help Inform Drug Performance Measures, Payers Say


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts